OpGen
OPGN
$0.51
Share price
-3.21%
Change (1 day)
-37.96%
Change (1 year)
Categories
OpGen (OPGN) - Total debt
Total debt on the balance sheet as of September 2023 : $12.55 M
According to OpGen 's latest financial reports the company's total debt is $12.55 M. A company’s total debt is the sum of all current and non-current debts.
OpGen - Total debt on balance sheet (from 2014 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2022-12-31 | $14.82 M | -41.13% |
| 2021-12-31 | $25.17 M | 10.2% |
| 2020-12-31 | $22.84 M | 623.05% |
| 2019-12-31 | $3.15 M | 66.71% |
| 2018-12-31 | $1.89 M | 46.26% |
| 2017-12-31 | $1.29 M | -4.34% |
| 2016-12-31 | $1.35 M | -13.94% |
| 2015-12-31 | $1.57 M | -51.41% |
| 2014-12-31 | $3.23 M | 824.22% |
| 2013-12-31 | $0.35 M |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Lexicon Pharmaceuticals
LXRX | $0.10 B | 744.44% | 🇺🇸 USA |
 Enzo Biochem ENZ | $7.18 M | -42.79% | 🇺🇸 USA |